Jumroendararasame Chaisiri, Panyakorn Somboon, Othong Rittirak, Jumroendararasame Auraya, Srimanan Worapot, Tipparut Kun
Department of Ophthalmology, Phramongkutklao Hospital, Bangkok, Thailand.
Medical Toxicology Unit, Department of Emergency Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
Am J Ophthalmol Case Rep. 2021 Dec;24:101212. doi: 10.1016/j.ajoc.2021.101212. Epub 2021 Sep 23.
The first reported case of bilateral transient visual field defect, experienced by an ophthalmologist, which developed shortly after COVID-19 vaccination (CoronaVac, Sinovac Biotech Ltd., Beijing, China) and confirmed by computerized automated perimetry.
The patient is a 42-year-old Thai ophthalmologist. He developed blurred vision within an hour after the second dose of COVID-19 vaccination. We described his self-observed of sequential symptoms, chronologic events, and management steps. The visual field of left congruous hemianopia with respect to vertical midline was detected with computerized automated perimetry. The possible mechanism could be related to an acute vasospasm of the artery in the postchiasmatic visual pathway, triggered by COVID-19 vaccine, Corona Vac.
With increasing use of the COVID-19 vaccine in the near future, it would be prudent for medical staff and ophthalmologists to be considered and aware of this associated condition.
首例由眼科医生报告的双侧短暂性视野缺损病例，该病例在接种新冠疫苗（科兴生物制品有限公司生产的克尔来福，中国北京）后不久出现，并经电脑自动视野计确认。
患者为一名42岁的泰国眼科医生。他在接种第二剂新冠疫苗后一小时内出现视力模糊。我们描述了他自我观察到的一系列症状、按时间顺序发生的事件以及处理步骤。通过电脑自动视野计检测到左侧相对于垂直中线的一致性偏盲视野。可能的机制可能与新冠疫苗克尔来福引发的视交叉后视觉通路动脉急性血管痉挛有关。
鉴于在不久的将来新冠疫苗的使用会越来越多，医护人员和眼科医生应考虑并知晓这种相关病症。
